Mechanisms and treatment of diarrhea in inflammatory bowel diseases

Inflammatory Bowel Diseases

Volumn 3, Issue 2, 1997, Pages 114-131

  Urayama, Shiro ^a   Chang, Eugene B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Diarrhea; Inflammatory bowel disease

Indexed keywords

EID: 0012853373     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780030207     Document Type: Article

References (8)

1. Wilson KT, Musch MW, Chang EB. Diarrhea in inflammatory bowel disease. In: MacDermott R, Stenson W, eds. Inflammatory bowel disease. New York: Elsevier Science, 1991:273-99.
2. Pearson AD, Eastman EJ, Laker MF, et al. Intestinal perme-ability in children with Crohn's disease and coeliac disease. Br Med J 1982;285:20-1.
3. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal pemeability in patients with Crohn's disease and their relations. Ann Intern Med 1986;105:883-5.
4. Bjornason I, O'Morain C, Levi AJ, Peters TJ. Absorption of 51-chromium labelled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenlerology 1983;85:318-22.
5. Marin ML, Greenstein AJ, Geller SA, et al. A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol 1983;78:537-47.
6. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and predictions of relapse in Crohn's disease. Lancet 1993;341:1437-9.
7. Lindberg E, Söderholm JD, Olaison G, Tysk C, Järnerot G. Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. Scand J Gastroenterol 1995:30:780-3.
8. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.